Abstract

Dr Christopher Chen Li Hsian is a Senior Clinician-Scientist at the National Medical Research Council of Singapore, Associate Professor at the Department of Pharmacology, Faculty of Medicine, National University of Singapore, and Director of the Memory Aging and Cognition Centre, National University Healthcare System.

His major research and clinical interests are the neurochemistry, molecular biology and treatment of stroke and dementia. He has published over 200 peer-reviewed papers and book chapters, served on several editorial boards (Stroke, Journal of Neurology Neurosurgery and Psychiatry), trial steering committees and data safety monitoring boards.

Since returning to Singapore in 1995, Dr Chen has developed a comprehensive multi-disciplinary dementia programme and encouraged collaborative research in the Asia-Pacific region and beyond. His focus is on developing a regional network for innovative trials into conditions prevalent and pertinent to Asia and to enhance Singapore’s capability for conducting increasingly sophisticated early phase studies utilising biomarkers such as neuroimaging.

Currently he is Secretary of the Asian Society Against Dementia; member of the Finance Sub-Committee of the World Federation of Neurology, International Stroke Society Board of Directors and Chairman of the International Society for Vascular Behavioural and Cognitive Disorders Executive Committee.